InvestSMART

Mayne Pharma Group Limited (ASX: MYX) - Announcements

Current share price for MYX : $2.820 0.03 (1.05%)+

ASX company news and announcements for Mayne Pharma Group Limited (MYX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Mayne Pharma Group Limited (MYX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Mayne Pharma Group Limited (MYX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Mayne Pharma Group Limited (MYX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$231 Mayne Pharma announces the acquisition of Kapanol 14 Dec 2012 9:46AM $0.320 $2.820 risen by 781.25%
$231 Trading Halt 14 Dec 2012 8:49AM $0.320 $2.820 risen by 781.25%
$231 2012 AGM CEO's Speech 9 Nov 2012 9:16AM $0.280 $2.820 risen by 907.14%
$231 Mayne Pharma announces in-licensing agreement 1 Nov 2012 11:14AM $0.270 $2.820 risen by 944.44%
$231 Retail Offer Booklet 12 Oct 2012 8:30AM $0.225 $2.820 risen by 1,153.33%
$231 Completion institutional entitlement/unconditional placement 8 Oct 2012 9:11AM $0.250 $2.820 risen by 1,028%
$231 Mayne Pharma Announces the Acquisition of Metrics, Inc. 4 Oct 2012 12:48PM $0.360 $2.820 risen by 683.33%
$231 Trading Halt 4 Oct 2012 10:04AM $0.360 $2.820 risen by 683.33%
$231 Media Speculation 24 Sep 2012 10:25AM $0.395 $2.820 risen by 613.92%
$231 Media Speculation 24 Sep 2012 9:47AM $0.395 $2.820 risen by 613.92%
$231 Preliminary Final Report 21 Aug 2012 2:12PM $0.355 $2.820 risen by 694.37%
$231 Mayne Pharma announces SUBACAP approvable 21 Jun 2012 9:45AM $0.375 $2.820 risen by 652%
$231 US Court decides on Doryx 161 Patent 1 May 2012 9:48AM $0.310 $2.820 risen by 809.68%
$231 Half Yearly Report and Accounts 28 Feb 2012 4:22PM n/a $2.820 n/a
$231 Doryx Generic Update 10 Feb 2012 12:37PM $0.320 $2.820 risen by 781.25%
$231 SUBACAP Update 15 Dec 2011 11:05AM $0.405 $2.820 risen by 596.30%
$231 Doryx Generic Update 13 Dec 2011 10:13AM $0.440 $2.820 risen by 540.91%
$231 MYX APPOINTS SCOTT RICHARDS AS CEO 2 Dec 2011 11:27AM $0.470 $2.820 risen by 500%
$231 Chairman`s Address to Shareholders 23 Nov 2011 10:22AM $0.480 $2.820 risen by 487.50%
$231 Doryx Generic Update 22 Sep 2011 10:07AM $0.370 $2.820 risen by 662.16%
$231 FDA Approval Of New Dual-Scored 150mg Doryx Tablet 14 Sep 2011 4:52PM $0.440 $2.820 risen by 540.91%
$231 Preliminary Final Report 31 Aug 2011 1:47PM $0.375 $2.820 risen by 652%
$231 Mayne Pharma Market Update 5 Jul 2011 12:10PM $0.400 $2.820 risen by 605%
$231 Mayne Pharma Market Update 15 Jun 2011 4:33PM $0.400 $2.820 risen by 605%
$231 Half Yearly Report and Accounts 25 Feb 2011 5:08PM $0.510 $2.820 risen by 452.94%

876 - 900 of 902 results

Page 36 of 37

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.